Wayne Holman, Ridgeback Capital:
Wayne Holman's hedge fund Ridgeback Capital Management
recently disclosed the purchasing of some 3.6 million shares of Sangamo Biosciences, Inc. (NASDAQ:SGMO
), a filing
with the SEC revealed. In this way, Ridgeback Capital Management initiated a position in the company by acquiring 5.9% of its shares, with the value of the stake amounting to almost $38.8 million.